Headline
The latest stories from AHA Today.
The departments of Health and Human Services, Labor, and the Treasury today issued a proposed rule that would allow consumers to buy short-term health plans of up to 364-days duration, eliminating the current less-than-three-months limit on short-term plans.
Responding to a request from Senate Finance Committee leaders for policy recommendations to address the opioid epidemic, AHA urged the committee Friday to preserve health insurance coverage through the exchanges and Medicaid.
Anthem last week notified network providers in Missouri, Kentucky and Georgia about changes to its program to prevent “avoidable” emergency department visits.
The AHA and its Health Research & Educational Trust affiliate have released a discussion guide, self-assessment tool and video modules to help hospital and health system trustees as they work to improve patient care in their organizations and communities.
John Riggi, a nationally recognized expert in health care cybersecurity who spent nearly 30 years with the Federal Bureau of Investigation, has joined the AHA as senior advisor for cybersecurity and risk.
The Maryland Hospital Association yesterday named as its new president and CEO Bob Atlas, currently president of EBG Advisors, the consulting affiliate of the health law firm of Epstein Becker Green.
The lower court incorrectly dismissed as premature their lawsuit to prevent a nearly 30% Medicare payment reduction for many hospitals in the 340B Drug Pricing Program, AHA and other hospital groups told a federal appeals court in a brief filed yesterday.
AHA today applauded the Office of the National Coordinator for Health Information Technology for pursuing a voluntary “network of networks” approach to the draft framework for trusted health information exchange that builds on existing efforts.
According to early estimates released yesterday, this season’s flu vaccine has been 36% effective overall at reducing the risk of having to go to the doctor.
The Substance Abuse and Mental Health Services Administration yesterday issued guidance for health care and addiction professionals using methadone, naltrexone or buprenorphine to treat patients with opioid use disorder.